Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma

Naoko Wada; Hiroshi Uchi; Masutaka Furue

doi:10.1111/1346-8138.13840

Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma

Naoko Wada, Hiroshi Uchi, Masutaka Furue

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e196-e197
Journal	Journal of Dermatology
Volume	44
Issue number	8
DOIs	https://doi.org/10.1111/1346-8138.13840
Publication status	Published - Aug 2017

All Science Journal Classification (ASJC) codes

Dermatology

Access to Document

10.1111/1346-8138.13840

Cite this

@article{56761df8e8694f339370b0925ee67bf9,

title = "Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma",

author = "Naoko Wada and Hiroshi Uchi and Masutaka Furue",

year = "2017",

month = aug,

doi = "10.1111/1346-8138.13840",

language = "English",

volume = "44",

pages = "e196--e197",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma

AU - Wada, Naoko

AU - Uchi, Hiroshi

AU - Furue, Masutaka

PY - 2017/8

Y1 - 2017/8

UR - http://www.scopus.com/inward/record.url?scp=85017636643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017636643&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.13840

DO - 10.1111/1346-8138.13840

M3 - Letter

C2 - 28391613

AN - SCOPUS:85017636643

VL - 44

SP - e196-e197

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 8

ER -

Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this